Coya Therapeutics sees success in early COYA-302 FTD trial, aims for Phase 2b in H2 2025 and ALS filing in Q2 2025. Read why COYA stock is a strong buy.

In high-performance environments like law firms, culture isn’t shaped by mission statements—it’s built in behaviors, ...

Ratledge scored highest on the Grit index in toughness, passion for the game, and leadership while also getting points for ...

In this exclusive interview, David Robert, director of human-robot interaction at Boston Dynamics , walks us through the ...

The IBM Global AI Adoption Index 2023 published in January 2024 concluded that 42% of enterprise level organizations have ...

A 9-foot tall bust of Elon Musk, inspired by the meme “Elon I Drew You / You Are My Hero, Elon,” stands off of Boca Chica ...

How do you react when XRP settles its legal battle, PI starts releasing millions of coins, and a fresh AI-based project rewards users for real online activity? You start paying closer attention. XRP’s ...

I had the pleasure of attending a Netflix event around the WoW documentary The Remarkable Life of Ibelin last year—one that ...

In the first quarter, the FDA granted Intellia the RMAT designation for nex-z for the treatment of ATTR with cardiomyopathy, which follows prior RMAT designations received for nex-z for ATTR with ...

C. Celebration of Excellence honors top students for academics, activities and service. Each chose an educator who inspired ...

Toms River Mayor Daniel Rodrick and Ocean County Republican George Gilmore might be in the same political party, but are not ...